Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer

Junyan Tao1,2, Junfang Ji3,4, Xiaolei Li2,5

  • 1School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, P.R. China.

Oncotarget
|March 13, 2015
PubMed

Insights

MicroRNAs (miRNAs) play a role in liver cancer. This study found that miR-101 acts as a tumor suppressor in hepatocellular carcinoma models, regardless of the specific oncogene driving the cancer, suggesting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA (miRNA) deregulation is common in human hepatocellular carcinoma (HCC).
  • The in vivo role of miRNAs during hepatocarcinogenesis is not well understood.
  • Distinct miRNA expression profiles are observed in mouse liver tumors induced by different oncogenes.

Purpose of the Study:

  • To investigate the in vivo relevance of specific downregulated miRNAs in hepatocarcinogenesis.
  • To determine the tumor suppressor activity of selected miRNAs in mouse models of liver cancer.
  • To assess the impact of oncogene-specific miRNA modulation on liver tumor development.

Main Methods:

  • Induction of liver tumors in mice using c-Myc or AKT/Ras overexpression.
  • Hydrodynamic transfection to overexpress selected miRNAs alongside oncogenes.
  • Evaluation of tumor suppressor activity of eight downregulated miRNAs (miR-101, miR-107, miR-122, miR-29, miR-365, miR-375, miR-378, miR-802).

Main Results:

  • Tumor suppressor activity of miRNAs varied significantly between c-Myc and AKT/Ras driven tumors.
  • miR-378 showed no tumor suppressor activity; miR-107, miR-122, miR-29, miR-365, and miR-802 had weak to moderate activity.
  • miR-375 demonstrated differential activity, inhibiting AKT/Ras driven tumors more effectively than c-Myc driven tumors.
  • miR-101 significantly suppressed tumor development in both c-Myc and AKT/Ras models.

Conclusions:

  • Different oncogenes induce distinct miRNA expression patterns that differentially impact hepatocarcinogenesis.
  • miR-101 exhibits potent tumor suppressor activity in liver cancer models, irrespective of the driving oncogene.
  • miR-101 represents a promising therapeutic target for human hepatocellular carcinoma.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

2.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K